Je veux savoir à propos de…

48433

Federal Register / Vol. 86, No. 165 / Monday, August 30, 2021 / Notices Policy for Extramural Research Administration, 6705 Rockledge Drive, 8th Floor Room 803, Bethesda, Maryland 20892, or call a non-toll-free number 3014350941 or Email your request, including your address to ProjectClearanceBranch@mail.nih.gov.
Formal requests for additional plans and instruments must be requested in writing.
Section 3506c2A of the Paperwork Reduction Act of 1995 requires: Written comments and/or suggestions from the public and affected agencies are invited to address one or more of the following points: 1 The necessity and utility of the proposed information collection for the proper performance of the agencys functions; 2 the accuracy of the estimated burden; 3 ways to enhance the quality, utility, and clarity of the information to be collected; and 4 the use of automated collection techniques or other forms of information
SUPPLEMENTARY INFORMATION:

technology to minimize the information collection burden.
Title of the Collection: NIH COVID19
Vaccine Attestation Intake Form.
Type of Collection: Emergency.
OMB Number: 0925NEW.
Abstract: The U.S. Office of Personnel Management OPM approved the U.S.
Department of Health and Human Services HHS request for a variation to a strict application of 5 CFR 339.205
under 5 CFR.1 to promote the efficiency of the Government. Under this variation, HHS may use the authority under 5 CFR
339.205 to mandate COVID19
vaccinations authorized under Emergency Use Authorizations EUA
for its patient-facing health care personnel, including its health care applicants and employees, who work in Indian Health Service IHS medical facilities, National Institutes of Health NIH clinical research facilities, or other HHS facilities that provide direct patient care or clinical research. In addition, the Safer Federal Workforce Task Force created by President Bidens
Executive Order 13991 has instructed Federal Agencies to inquire about the COVID19 vaccination status of federal employees and on-site contractors. The NIH now has a COVID19 vaccination requirement for persons working in Building 10 on the Bethesda campus, those with patient contact, or probable patient contact. The proposed information collection will be used to ensure compliance with these requirements, generate the list of persons required to be tested on a routine basis, and will provide important information regarding safety frameworks, guidance, and procedures.
The purpose of the information collection is to promote the safety of the federal workplace consistent with the above-referenced authorities, the COVID19 Workplace Safety: Agency Model Safety Principles established by the Safer Federal Workforce Task Force, and guidance from the Centers for Disease Control and Prevention CDC
and the Occupational Safety and Health Administration OSHA.

ESTIMATED ANNUALIZED BURDEN TABLE
Type of collection
Number of respondents
Average burden per response in hours
Total burden hours
NIH COVID19 Vaccine Attestation intake form

31,000

1

5/60

2,583

Total

31,000

2,583

Dated: August 24, 2021.
Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health.
FR Doc. 202118636 Filed 82721; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Meetings
khammond on DSKJM1Z7X2PROD with NOTICES

Number responses per respondent
Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of meetings of the National Advisory Allergy and Infectious Diseases Council.
The meeting will be open to the public. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website http videocast.nih.gov.
Individuals who need special assistance, such as sign language interpretation or other reasonable
VerDate Sep<11>2014

18:40 Aug 27, 2021

Jkt 253001

accommodations, should notify the Contact Person listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Allergy and Infectious Diseases Council Date: September 13, 2021
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Director Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4G30
Rockville, MD 20892 Virtual Meeting.
Closed: 11:45 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases, National Institutes of
PO 00000

Frm 00049

Fmt 4703

Sfmt 4703

Health, 5601 Fishers Lane, Room 4G30
Rockville, MD 20892 Virtual Meeting.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD, 20892 3014967291, fentonm@
niaid.nih.gov.
Name of Committee: National Advisory Allergy and Infectious Diseases Council Acquired Immune Deficiency Syndrome Subcommittee.
Date: September 13, 2021.
Open 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4G30, Rockville, MD 20832 Virtual Meeting.
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4G30, Rockville, MD 20892 Virtual Meeting.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD

E:FRFM30AUN1.SGM

30AUN1